In an exclusive interview with Outsourcing Pharma, Mr Weinstein explains why he believes he and his collegues were singled out for criticism, and sheds some light on where the battle lines have been drawn in the ongoing dispute.
Headlines > Clinical Development
Exclusive interview
BioClinica bites back at Nicusa Capital's call for leadership changes
Related topics: Clinical Development, Phase I-II, Phase III-IV
Mark Weinstein, CEO of Bioclinica, has hit back at a public letter from Nicusa Capital CEO, Paul Johnson, claiming that the company's corporate strategy is 'flawed' and demanding the resignation of three top executives.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
Latest news in Clinical Development
Related products & Suppliers
SGS adds formulation development services and expands US lab
Eric Hoffman
VP Business development and marketing - North America, SGS Life...
Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst
Aiswariya Chidambaram
Market Analyst, Frost & Sullivan
Improve patient compliance by designing trials around real life, says expert
Rahlyn Gossen
Owner, Rebar Interactive
Regulatory changes: the experts give us their thoughts at DIA Euromeeting
Various
Various, DIA Euromeeting, 2012
Catalent eyes emerging market expansion of end-to-end development service model
Carolyn Finkle
VP of global regulatory consulting , Catalent
Comparator sourcing is a complex challenge in a globalised market says Clinigen
Peter George
CEO, Clinigen Group
Pharma needs to rethink supply chains in an era of patent expiry and global outsourcing
Hedley Rees
Industry consultant , Biotech Pharmaflow
European CMO market will double in just 6 years, says Frost & Sullivan
Aiswariya Chidambaram
Healthcare market analyst, Frost & Sullivan
Social networking is key to trial recruitment success, says expert
Jamie Blackburn
Founder, Patient Nucleus
An experienced CMO is key to successful biologics development says Cobra Biologics
Julian Hanak
Commercial director, Cobra Biologics
Sponsors and CROs differ on perception of service quality, says the Avoca Group
Patricia Leuchten
CEO, The Avoca Group
Embedded service providers are future of the industry, says RPS
Joseph Camero
Executive recruiter, RPS
Almac sees growing demand for non-GMP contracting
David Downey
VP Commercial Operations, Almac Pharma Services
The right questions key to assessing CRO performance, says study team
Dr Michael Howley
Associate Clinical Professor , LeBow College of Business, Drexel University
CROs' complex demands are changing the tissue supply biz, says industry expert
Vadim Alexandre
equity analyst, Daniel Stewart & Company
Pharma sponsors want better quality CRO performance data, says CRO Analytics
Peter Malamis
CRO Analytics
Patient Recruitment Outsourcing in emerging markets: the good, the bad, and the ugly
Shaylyn Pike
Head of emerging markets research team, Cutting Edge Information
Patient recruitment must evolve, says Cutting Edge Information
Eric Bolesh
Director of research, Cutting Edge Information
Patient recruitment best outsourced, says market analyst
Eric Bolesh
Director of research, Cutting Edge Information
Realistic, evidence-based patient recruitment goals are key, Shire
Joseph Kim
Director of Clinical Operations, Shire Pharmaceuticals
Firecrest's site performance software goes mobile
Nigel Hughes
Head of Business Development, Firecrest Clinical
Biopharm waste material mix a chance to cut landfill costs
Lucy Russell
security shredding manager , Smurfit Kappa Recycling
Patheon launches CMC consultancy in face of restructuring plans
Geoff Glass
Executive VP of global sales and marketing, Patheon
Parexel discusses transdermal drug delivery techs
Ravi Harapanhalli
Principal Consultant and Practice Lead for Late Stage Product Development...
Quotient says screening of prototype formulations is crucial to drug delivery
Peter Schole
VP, pharmaceutical sciences, Quotient Clinical
Covance adding mass spec for biosimilars
Ray Kaiser
Chief Scientific Officer, Biotechnology, Covance
Patheon mulls drug delivery tech deals to accelerate development services growth
Mark Kontny
President, Global Pharmaceutical Development Services, Patheon
Catalent eyes acquisitions in emerging market and drug delivery expansion
Scott Houlton
President, Development and Clinical Services, Catalent
Icon sets its sights on genomics development
Brian O’Dwyer
senior VP for global bioanalytical services, Icon
Norwich amps up its pilot scale production capabilities at NY plant
Terry Novak
President, Norwich Pharmaceuticals
Novozymes reveals the key to its supply chain management strategy
Luke Dimasi
marketing manager, Novozymes
New growth strategy and supply chain management system in place for SAFC, says president Gilles Cottier
Gilles Cottier
President, SAFC
Rapid recruitment in emerging regions can overload sites; FDA
Cynthia Kleppinger
Medical Officer, Division of Scientific Investigations, CDER, FDA
Sponsors and CROs both have key role in quality; FDA
Ann Meeker O’Connell
Acting Associate Director of Risk Science, Intelligence & Prioritization, FDA
ACRO, Quintiles, PRA and Theorem talk strategic partnering at DIA 2011
The Big Pharma CRO strategic partnering model, its impact on drug development and the...
OSP meets Pfizer's REMOTE virtual trial partners at DIA 2011
In June global drug giant Pfizer began what it described as the world’s first...
Quintiles talks about challenges of data management in today’s trials sector
Paula Brown Stafford
President, Clinical Development, Quintiles
Fiscal benefits of drugs a priority for cash-strapped countries
Geoff Fatzinger
director of regulatory affairs and strategic product development, INC Research
Strategic relationships are changing Pharma and CRO skillset says Parexel
Joshua Schultz
corporate VP of strategic account leadership, Parexel
Parexel talks global trial regulations at DIA 2011
Alberto Grignolo
Corporate Vice President, Global Strategy and Services, Parexel International
Chiltern says strategic deals are good for the CRO sector
Aize Smink
Senior Executive VP, Global Clinical Development, Chiltern
Quintiles launches silo busting data management platform at DIA
Thomas Grundstrom
VP of global data solutions, Quintiles
Celerion talks about research sector in South America
US CRO Celerion gained Brazilian National Health Surveillance Agency (Agência Nacional de Vigilancia Sanitaria...
PRA reflects on data and information management at DIA
Steve Powell
Senior VP of clinical informatics and late phase services ,...
Medidata to add SaaS CTMS through Clinical Force buy
Graham Bunn
Vice president of partnerships and alliances, Medidata
Almac talks expansion at Interphex 2011
James McGibbon
direstor of business development, pharma services, Almac
EDT talks about the contract manufacturing market at Interphex
Philip Pratten
Vice president, manufacturing services operations, Elan Drug Technologies
Patheon talks about backup manufacturing service at Interphex 2011
Geoffrey Glass
Executive VP of Global Strategy, sales and marketing, Patheon